KJ

Kinjal Jaysukhbhai Sojitra

Active Director Director DIN 09024900
DIN 09024900 First appointment Jan 2021 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Kinjal Jaysukhbhai Sojitra

Data last updated:

Kinjal Jaysukhbhai Sojitra is a Director at Seequance Clinical Research Private Limited (since 2021). The company operates in Research & Development.

DIN 09024900
Primary Designation Director
Industry Research & Development
First Appointment 09 Jan 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jan 20212021Active

Board colleagues of Kinjal Jaysukhbhai Sojitra

Directorship timeline

Open interactive timeline →
Seequance Clinical Research Private Limited
Premium access

Shareholding and investment profile for Kinjal Jaysukhbhai Sojitra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kinjal Jaysukhbhai Sojitra

Kinjal Jaysukhbhai Sojitra currently holds 1 directorship: Seequance Clinical Research Private Limited (Director, since 09 Jan 2021).

Kinjal Jaysukhbhai Sojitra was first appointed on 09 Jan 2021 as Director at Seequance Clinical Research Private Limited.

The current boards of Kinjal Jaysukhbhai Sojitra's companies include Tushar Jaysukhbhai Sojitra (Seequance Clinical Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available